Global Tuberculosis (TB) Diagnostics Market 2017-2021 - Product Image

Global Tuberculosis (TB) Diagnostics Market 2017-2021

  • ID: 4424953
  • Report
  • Region: Global
  • 91 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott
  • Ameritek USA
  • BD
  • Cepheid
  • F. Hoffmann-La Roche
  • Hain Lifescience
  • MORE
About Tuberculosis (TB) Diagnostics

TB is a contagious infection that usually attacks the lungs. It may also spread to other parts of the body such as the brain and the spine. TB commonly spreads through the air when an infected person coughs, sneezes, spits, laughs, or talks. Mycobacterium tuberculosis is responsible for the onset of the disease. In the 20th century, TB was a leading cause of death. However, today, most cases are cured with antibiotics, which is a time-consuming process. Medicines should be taken for at least six to nine months.

The analysts forecast the global tuberculosis (TB) diagnostics market to grow at a CAGR of 3.56% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global tuberculosis (TB) diagnostics market for 2017-2021. To calculate the market size, the report considers the new installations, shipments, sales, volume, and value.
The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Tuberculosis (TB) Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott
  • BD
  • bioMérieux
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
Other prominent vendors
  • Akonni Biosystems
  • Ameritek USA
  • Autobio Diagnostics
  • Cepheid
  • EIKEN CHEMICAL
  • GeTein BioMedical
  • Hain Lifescience
  • Hologic
  • NanoEnTek
  • Ortho Clinical Diagnostics
  • QIAGEN
  • Siemens Healthineers
Market drivers
  • Increasing prevalence of TB
  • For a full, detailed list, view the full report
Market challenges
  • Accessibility and cost constraints of advanced TB diagnostics
  • For a full, detailed list, view the full report
Market trends
  • Expansion of healthcare infrastructure
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Ameritek USA
  • BD
  • Cepheid
  • F. Hoffmann-La Roche
  • Hain Lifescience
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION
  • Overview
PART 05: MARKET LANDSCAPE
  • Overview
  • Market size and forecast
  • Five forces analysis
PART 06: SEGMENTATION BY PRODUCT TYPE
  • Overview
  • Culture
  • Mantoux tuberculin test
  • Molecular testing
  • Smear microscopy
  • LF-LAM for PLHIV
  • Drug susceptibility testing
PART 07: SEGMENTATION BY END-USER
  • Overview
  • Hospitals
  • Diagnostic laboratories
PART 08: SEGMENTATION BY GEOGRAPHY
  • Overview
  • Regional comparison
  • APAC
  • Americas
  • EMEA
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Focus on partnerships and acquisitions for product development
  • Continuous technological advances
  • Expansion of healthcare infrastructure
PART 12: VENDOR LANDSCAPE
  • Competitive landscape
PART 13: KEY VENDOR ANALYSIS
  • Abbott
  • BD
  • bioMérieux
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Other prominent vendors
PART 14: APPENDIX
  • List of abbreviations
LIST OF EXHIBITS
Exhibit 01: Share of global TB diagnostics market of global IVD market 2016 (%)
Exhibit 02: Global TB diagnostics market 2016-2021 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global TB diagnostics market: Segmentation by product type 2016 (% share)
Exhibit 05: Global TB diagnostics market: Segmentation by end-user 2016 (% share)
Exhibit 06: Global TB diagnostics market by hospitals 2016-2021 ($ billions)
Exhibit 07: Global TB diagnostics market by hospitals: Year-over-year growth 2017-2021 (%)
Exhibit 08: Global TB diagnostic market by diagnostic laboratories 2016-2021 ($ billions)
Exhibit 09: Global TB diagnostics market by diagnostic laboratories: Year-over-year growth 2017-2021 (%)
Exhibit 10: Global TB diagnostics market: Segmentation by geography 2016-2021 (% share)
Exhibit 11: Global TB diagnostics market: Regional comparison
Exhibit 12: TB diagnostics market in APAC: Overview
Exhibit 13: TB diagnostics market in APAC 2016-2021 ($ billions)
Exhibit 14: TB diagnostics market in APAC: Year-over-year growth 2017-2021 (%)
Exhibit 15: TB diagnostics market in Americas: Overview
Exhibit 16: TB diagnostics market in Americas 2016-2021 ($ billions)
Exhibit 17: TB diagnostics market in Americas: Year-over-year growth 2017-2021 (%)
Exhibit 18: TB diagnostics market in EMEA: Overview
Exhibit 19: TB diagnostics market in EMEA 2016-2021 ($ billions)
Exhibit 20: TB diagnostics market in EMEA: Year-over-year growth 2017-2021 (%)
Exhibit 21: Global TB diagnostics market: Key leading countries
Exhibit 22: Global TB diagnostics market: Competitive structure analysis 2016
Exhibit 23: Abbott: Key highlights
Exhibit 24: Abbott: Strength assessment
Exhibit 25: Abbott: Strategy assessment
Exhibit 26: Abbott: Opportunity assessment
Exhibit 27: BD: Key highlights
Exhibit 28: BD: Strength assessment
Exhibit 29: BD: Strategy assessment
Exhibit 30: BD: Opportunity assessment
Exhibit 31: bioMérieux: Key highlights
Exhibit 32: bioMérieux: Strength assessment
Exhibit 33: bioMérieux: Strategy assessment
Exhibit 34: bioMérieux: Opportunity assessment
Exhibit 35: F. Hoffmann-La Roche: Key highlights
Exhibit 36: F. Hoffmann-La Roche: Strength assessment
Exhibit 37: F. Hoffmann-La Roche: Strategy assessment
Exhibit 38: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 39: Thermo Fisher Scientific: Key highlights
Exhibit 40: Thermo Fisher Scientific: Strength assessment
Exhibit 41: Thermo Fisher Scientific: Strategy assessment
Exhibit 42: Thermo Fisher Scientific: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Ameritek USA
  • BD
  • Cepheid
  • F. Hoffmann-La Roche
  • Hain Lifescience
  • MORE
New Report Released: - Global Tuberculosis (TB) Diagnostics Market 2017-2021

The author of the report recognizes the following companies as the key players in the global tuberculosis (TB) diagnostics market: Abbott, BD, bioMérieux, F. Hoffmann-La Roche, and Thermo Fisher Scientific

Other Prominent Vendors in the market are: Akonni Biosystems, Ameritek USA, Autobio Diagnostics, Cepheid, EIKEN CHEMICAL, GeTein BioMedical, Hain Lifescience, Hologic, NanoEnTek, Ortho Clinical Diagnostics, QIAGEN, and Siemens Healthineers.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is Expansion of healthcare infrastructure. Healthcare infrastructure has constantly been expanding across the world. Efforts have also been made to make diagnostic facilities available in rural areas. People are encouraged to visit clinics or healthcare facilities in the vicinity to diagnose and treat diseases. This could reduce the burden of large test volumes from large hospitals. It would also reduce the burden of healthcare expenses rural and semi-urban populations. This is because out of pocket expense would decrease.”

According to the report, one of the major drivers for this market is Increasing prevalence of TB. TB affects a significant proportion of the population each year. In 2015, it was one of the 10 major causes of death, ranking above acquired immunodeficiency syndrome (AIDS). However, TB can be cured through early diagnosis and treatment.

Further, the report states that one of the major factors hindering the growth of this market is Accessibility and cost constraints of advanced TB diagnostics. New and improved diagnostics can reform TB diagnostics. However, it is important to make them accessible in clinics when patients initially seek medical attention for TB. For instance, despite its various features, Xpert was not considered as a POC test. It requires controlled environmental temperatures and continuous power supply, which are not generally accessible in the primary healthcare centers of low-income countries. It is indicated that the full advantage of enhanced diagnostic tests can only be felt if they are actualized as POC tests. Hence, new diagnostic tests must be designed for low-income countries. The equipment, skills, and environmental controls in peripheral laboratories are often limited.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott
  • BD
  • bioMérieux
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Akonni Biosystems
  • Ameritek USA
  • Autobio Diagnostics
  • Cepheid
  • EIKEN CHEMICAL
  • GeTein BioMedical
  • Hain Lifescience
  • Hologic
  • NanoEnTek
  • Ortho Clinical Diagnostics
  • QIAGEN
  • Siemens Healthineers
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll